Showing results (41-50 of 597) with videos related to
Sort By:
Pageof 60
Cancer Diagnosis & Prognosis|April 11, 2022
Impact of Hypertension on Early Renal Dysfunction in Japanese Prostate Cancer Patients Treated With Androgen Deprivation TherapyHiroshi Masuda, Masahiro Sugiura, Kyokusin Hou, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Successful Response to Nivolumab Plus Ipilimumab Therapy in a Hemodialysis Patient With Metastatic Renal Cell CarcinomaHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Immune Checkpoint Inhibitor for Non-small Cell Lung Cancer With Negative or Low Tumor PD-L1 ExpressionMinehiko Inomata, Naoki Takata, Isami Mizushima, et al.Cancer Diagnosis & Prognosis|April 11, 2022
A Treatment-free Interval Allowed by Ponatinib as Fourth-line TherapyAnna Bulla, Uros Markovic, Claudia Bellofiore, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Treatment at an Inexperienced Center Suggests Worse Prognosis of Metastatic Germ Cell TumorsHiroshi Yaegashi, Kouji Izumi, Suguru Kadomoto, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Switching Patients With Prostate Cancer from GnRH Antagonist to Long-acting LHRH Agonist for Androgen Deprivation: Reducing Hospital Visits During the Coronavirus PandemicMotohiro Fujiwara, Takeshi Yuasa, Yoshinobu Komai, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Inflammation-based Indexes Upon Adjuvant Chemotherapy Initiation as a Predictor of Relapse After Curative Resection of Colorectal Cancer With an Oxaliplatin-based RegimenMasaya Satake, Kazuhiko Yoshimatsu, Masano Sagawa, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Preoperative Predictors of Lymph Node Invasion and Biochemical Recurrence in High-risk Prostate CancerYohei Shida, Tomoaki Hakariya, Kensuke Mitsunari, et al.Cancer Diagnosis & Prognosis|April 11, 2022
Somatic Mutations in TP53 Gene in Colombian Patients With Non-melanoma Skin CancerLuz Dary Gutiérrez-Castañeda, John Nova, María Irene Cerezo-CortésCancer Diagnosis & Prognosis|April 11, 2022
Complete Response of a Mutated BRCA2 Metastatic Clear Cell Endometrial Adenocarcinoma to the Poly (ADP ribose) Polymerase (PARP) Inhibitor OlaparibDimitri Anzellini, Gianluca Arcangeli, Sergio Del BiancoPageof 60